Search Within

Breast Medicine Service

Formats
  1. Journal Article (2206)
  2. Meeting Abstract (1680)
  3. Review (83)
  4. Book Section (69)
  5. Editorial (44)
  6. Conference Paper (28)
  7. Guidelines (27)
  8. Correspondence (16)
  9. Miscellaneous (12)
  10. Research Letter (11)
  11. Book Whole (5)
Groups
  1. Department of Medicine (4181)
  2. Solid Tumor Oncology Division (4181)
  3. Survivorship Research (2373)
  4. GSK Faculty (1516)
  5. Population Sciences Research Program (1369)
  6. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (1144)

More Groups

People
  1. Clifford Hudis (906)
  2. Larry Norton (762)
  3. Mark Robson (684)
  4. Neal Rosen (427)
  5. Andrew Seidman (319)
  6. Kenneth Offit (300)

More People

Years
  1. 2025 (130)
  2. 2024 (195)
  3. 2023 (168)
  4. 2022 (219)
  5. 2021 (236)
  6. 2020 (250)

More Years

Publications
  1. Journal of Clinical Oncology (828)
  2. Cancer Research (481)
  3. Breast Cancer Research and Treatment (170)
  4. Annals of Oncology (159)
  5. Clinical Cancer Research (132)
  6. Cancer (78)

More Publications

Publishers
  1. American Society of Clinical Oncology (880)
  2. American Association for Cancer Research (755)
  3. Springer (332)
  4. Elsevier Inc. (308)
  5. Oxford University Press (282)
  6. Nature Publishing Group (276)

More Publishers

Results (4181)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Pharmacokinetics (PK) of trastuzumab-DM1 (T-DM1) and paclitaxel (T) in patients with HER2-positive locally advanced or metastatic breast cancer (MBC) previously treated with a trastuzumab-containing regimen
    Meeting Abstract

    Lu, D.; Krop, I.; Modi, S.; Elias, A.; LoRusso, P.; Huang, J.; Lu, M.; Girish, S.
    Cancer Research (2010)

    Fulltext@MSK | Save
  • Symptomatic congestive heart failure after neo/adjuvant dose-dense epirubicin: A retrospective analysis of two trials with long-term follow-up
    Meeting Abstract

    Gajria, D.; Pokuri, V.; Steingart, R.; Hudis, C.; Dang, C.
    Cancer Research (2010)

    Fulltext@MSK | Save
  • PI3K mutations are more common in low grade DCIS
    Meeting Abstract

    Sakr, R.; Chandarlapaty, S.; Andrade, V.; Giri, D.; Muhsen, S.; Paik, W.; Morrow, M.; Rosen, N.; King, T.
    Cancer Research (2010)

    Fulltext@MSK | Save
  • Oncology clinicians' knowledge, attitudes and practices regarding fertility preservation
    Meeting Abstract

    Goldfarb, S. B.; Dickler, M. N.; McCabe, M. S.; Thom, B.; Jia, X.; Margolies, A.; Norton, L.; Hudis, C.; Basch, E.; Kelvin, J. F.
    Cancer Research (2010)

    Fulltext@MSK | Save
  • Adherence, persistence and toxicity with oral CMF in older women with early stage breast cancer in CALGB 49907 (Adherence companion study 60104)
    Meeting Abstract

    Ruddy, K. J.; Archer, L. E.; Cohen, H. J.; Winer, E. P.; Hudis, C. A.; Muss, H. B.; Partridge, A. H.
    Cancer Research (2010)

    Fulltext@MSK | Save
  • A novel capecitabine schedule (7 on—7 off) is feasible with lapatinib for patients with HER2-positive metastatic breast cancer refractory to trastuzumab
    Meeting Abstract

    Gajria, D.; Theodoulou, M.; Feigin, K.; Patil, S.; Geneus, S.; Drullinsky, P.; D'Andrea, G.; Lake, D.; Norton, L.; Hudis, C.; more...
    Cancer Research (2010)

    Fulltext@MSK | Save
  • A Phase 3 randomized, controlled trial of myocet, trastuzumab and paclitaxel vs. trastuzumab and paclitaxel for 1st line therapy of HER2+ metastatic breast cancer
    Meeting Abstract

    Baselga, J.; Manikhas, A.; Roman, L.; Semiglazov, V.; Goldfarb, R. H.; Forenza, S.; Matera, J.; Azarnia, N.; Hudis, C.; Rozencweig, M.
    Cancer Research (2010)

    Fulltext@MSK | Save
  • Challenges to clinical application of new discoveries in the genetics of breast cancer predisposition
    Meeting Abstract

    Robson, M. E.
    Cancer Research (2010)

    Fulltext@MSK | Save
  • Patient perspectives on information communicated regarding effects of treatment on fertility
    Meeting Abstract

    Goldfarb, S. B.; Kelvin, J. F.; Thom, B.; Kaplan, J.; Corcoran, S.; Margolies, A.; McCabe, M. S.; Norton, L.; Hudis, C.; Basch, E.; more...
    Cancer Research (2010)

    Fulltext@MSK | Save
  • A phase I-II trial of dasatinib (D) in combination with weekly (w) paclitaxel (P) for patients (Pts) with metastatic breast carcinoma (MBC)
    Meeting Abstract

    Morris, P. G.; Abbruzzi, A.; D'Andrea, G.; Gilewski, T.; Lake, D.; Bromberg, J.; Dang, C.; Dickler, M.; Modi, S.; Seidman, A. D.; more...
    Cancer Research (2010)

    Fulltext@MSK | Save